Hangzhou Jiuge Biotech advances membrane protein production with P2X1 antibody P007
EU Reporter —
Hangzhou Jiuge Biotech’s innovative membrane protein production technology creates collaboration opportunities for the European pharmaceutical industry. (Source: Hangzhou Jiuge Biotech) Amid rising R&D costs and increasing innovation challenges in the global pharmaceutical industry, Hangzhou Jiuge Biotech, a Chinese biotech company, has achieved a significant breakthrough in membrane protein production, opening new possibilities for international pharmaceutical […]